期刊文献+

低共熔溶剂对酶的影响及应用研究 被引量:1

Effects of Deep Eutectic Solvents on Enzyme
原文传递
导出
摘要 低共熔溶剂是由一定化学计量比的氢键受体和氢键供体组合而成的新型绿色溶剂,具有成本低、易制备、环境友好等特点,可以作为普通有机溶剂和离子液体的替代溶剂。酶作为生物催化剂时反应条件温和,对反应底物专一性高,并且具有极高的催化效率和反应速度。酶促反应通常发生在水溶液体系,但近年来发现在低共熔溶剂中酶促反应也能有效进行。综述酶与低共熔溶剂共同作用的机理以及低共熔溶剂在酶促反应中的应用,展望未来的研究方向,为酶促反应体系的进一步开发奠定理论基础。 Deep eutectic solvent is a new type of green solvent,which is composed of hydrogen bond acceptor and hydrogen bond donor with a certain stoichiometric ratio.It has low preparation cost and is friendly to the environment.It can be used as an alternative solvent for ordinary organic solvents and ionic liquids.As a biocatalyst,enzyme has mild reaction conditions,high substrate specificity,and high catalytic efficiency and reaction speed.Enzymatic reaction usually occurs in aqueous solution,but recently it has been found that it can also be carried out effectively in deep eutectic solvents.In order to better understand the effects of deep eutectic solvents on enzyme,the mechanism of the interaction between enzyme and deep eutectic solvents and the latest progress in application are systematically discussed.At the same time,the advantages and disadvantages of deep eutectic solvents in enzymatic reaction are evaluated.Finally,the future development prospects are discussed.
作者 赵楠杉 赵亚鑫 张海花 杨东风 梁宗锁 郭建军 ZHAO Nan-shan;ZHAO Ya-xin;ZHANG Hai-hua;YANG Dong-feng;LIANG Zong-suo;GUO Jian-jun(College of Life Sciences and Medicine,Zhejiang Sci-tech University,Hangzhou 310018,China;Zhejiang Sci-techUniversity Shaoxing Academy of Biomedicine,Shaoxingg 312090,China)
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2022年第12期111-119,共9页 China Biotechnology
基金 浙江省“尖兵”“领雁”研发攻关计划(2022C02023)资助项目。
关键词 低共熔溶剂 催化 Deep eutectic solvents Enzyme Catalysis
  • 相关文献

参考文献9

二级参考文献76

  • 1应以坚,王雪奇.生物产品甜菊苷综述[J].轻工科技,2012,28(1):9-10. 被引量:2
  • 2屠振密.电沉积锌与锌基合金的现状与发展[J].电镀与精饰,1994,16(3):3-3. 被引量:16
  • 3杨坤,华一新.离子液体电沉积铜及其合金的研究现状[J].冶金丛刊,2007(4):40-45. 被引量:6
  • 4Schoemaker H E, Mink D, Wubbolts M G. Dispelling the myths - Biocatalysis in industrial synthesis. Science,2003,299(5613) : 1694-1697.
  • 5Yu H M, Yin J. Construction and selection of the novel recombinant Escherichia coli strain for poly (beta-hydroxybutyrate) production. Journal of Bioscience and Bioengineering, 2000,89 (4) : 307-311.
  • 6De Carvalho C, Da Fonseca M. Biotransformation of terpenes. Biotechnology Advances,2006,24(2) : 134-142.
  • 7Dai J G, Qu R J, Zou J H, et al. Structural diversification of taxanes by whole-cell biotransformation. Tetrahedron, 2008,64 (35) : 8102-8116.
  • 8Peng Y L, Demain A L. Bioconversion of compactin to pravastatin by Actinomadura sp. ATCC 55678. Journal of Molecular Catalysis B: Enzymatic,2000,10(1-3) : 151-156.
  • 9Park J W, Lee J K, Kwon T J, et al. Bioconversion of compactin into pravastatin by Streptomyces sp. Biotechnology Letters, 2003, 25(21) : 1827-1831.
  • 10Wang F Q, Li B, Wang W, et al. Biotransformation of diosgenin to nuatigenin-type steroid by a newly isolated strain, Streptomyces virginiae IBL-14. Applied Microbiology and Biotechnology,2007, 77 : 771-777.

共引文献31

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部